These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5120610)

  • 21. Morphology of the bone marrow, spleen and liver during hematopoietic cell mobilization with cyclophosphamide in mice.
    Barcew K; Karbicka A; Szumilas P; Marchlewicz M; Grzegrzółka R; Wiszniewska B; Machaliński B
    Folia Histochem Cytobiol; 2008; 46(4):501-9. PubMed ID: 19141405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
    Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunosuppression with busulphan: the effect on spleen, marrow and thymus cells of mice.
    Addison IE
    Eur J Immunol; 1973 Jul; 3(7):419-24. PubMed ID: 4586171
    [No Abstract]   [Full Text] [Related]  

  • 24. Repair processes of hemopoiesis after applying cyclophosphamide. I. Morphological changes in the bone marrow, spleen and thymus.
    Macková N; Süliová J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):596-604. PubMed ID: 2435625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experiments in the immunization of hybrid F1 mice against leukemia L1210].
    Brambilla G; Cavanna M; Parodi S; Baldini L
    Arch Ital Patol Clin Tumori; 1968; 11(3):253-61. PubMed ID: 5737806
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the immunosuppressive properties of two related dimethanesulfonates.
    Vadlamudi S; Waravdekar VS; Goldin A
    Chem Biol Interact; 1971 Oct; 3(5):363-70. PubMed ID: 5003204
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship between granulocytic and erythroid repopulating ability.
    Constable TB; Blackett NM
    Exp Hematol; 1974; 2(3):131-7. PubMed ID: 4616841
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of murine leukemia chemotherapy according to the immune state: reconsideration of correlations between chemotherapy, tumour cell killing, and survival time.
    Mathé G; Halle-Pannenko O; Bourut C
    Recent Results Cancer Res; 1977; (62):9-12. PubMed ID: 304590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classes.
    de Jong JP; Nikkels PG; Brockbank KG; Ploemacher RE; Voerman JS
    Cancer Res; 1985 Sep; 45(9):4001-5. PubMed ID: 3896474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1974 Oct; 10(10):661-6. PubMed ID: 4465103
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticancer activities of methanesulfonic acid esters of aminoglycols against mouse leukemia L-1210.
    el-Merzabani MM; Sakurai Y
    Gan; 1967 Apr; 58(2):199-201. PubMed ID: 6075181
    [No Abstract]   [Full Text] [Related]  

  • 34. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.
    van Putten LM; Lelieveld P
    Eur J Cancer (1965); 1971 Feb; 7(1):11-6. PubMed ID: 5576726
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of cyclophosphamide on hemic precursor cells in mouse bone marrow and spleen.
    Wierda D; Pazdernik TL
    J Immunopharmacol; 1979; 1(3):357-76. PubMed ID: 553112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a homologous series of dimethane-sulphonoxy-alkanes on haemopoietic colony forming units in the rat.
    Dunn CD; Elson LA
    Chem Biol Interact; 1970 Dec; 2(4):273-80. PubMed ID: 5524090
    [No Abstract]   [Full Text] [Related]  

  • 37. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
    Presant CA; Coulter D; Valeriote F; Vietti TJ
    J Natl Cancer Inst; 1981 Jun; 66(6):1151-4. PubMed ID: 6165854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytohemagglutinin and hematopoietic stem cells in the mouse.
    Scaro JL; Carrera MA; Teruel JE; Alvarez Prado de Tombol
    Acta Haematol; 1971; 46(5):275-81. PubMed ID: 5005906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.